Drug Trial Radar · NCT07094087
Efficacy and Safety of 4F-PCC (4-Factor Prothrombin Complex Concentrate) in Adult Patients Undergoing Complex Cardiovascular Surgery With Cardiopulmonary Bypass (CPB)
Last checked: Nov 19, 2026Latest source record: Oct 15, 2026 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Recruiting
Enrollment
200
Planned (sponsor's estimate)
Start
Sep 15, 2025
Primary completion
Apr 6, 2027
Study completion May 5, 2027
Sponsor
- Lead sponsor
- CSL BehringIndustry
- Sponsor type
- Industry
- First posted
- Jul 30, 2025
Design
- Study type
- Interventional
- Phase
- Phase 3
- Allocation
- Randomized
- Model
- Parallel
- Masking
- None
- Primary purpose
- Treatment
- FDA-regulated drug
- Yes
- Who can join
- All sexes, from 18 years
- Healthy volunteers
- No
Summary
As written by the sponsor on the registry.
This is a phase 3, multicenter, randomized, open-label, parallel-group, controlled study to assess the efficacy and safety of BE1116 compared with fresh frozen plasma (FFP) in adult participants undergoing complex cardiovascular surgery with CPB. The primary purpose of the study is to compare the efficacy of BE1116 and FFP in correcting coagulation factor deficiencies in bleeding participants undergoing complex cardiovascular surgery with CPB.
Conditions
- Complex Cardiovascular Surgery With Cardiopulmonary Bypass
Interventions
BE1116Biological
A single dose of BE1116 will be administered by intravenous (IV) infusion intraoperatively.
FFPBiological
A single dose of FFP will be administered as investigational product (IP) by IV infusion intraoperatively.
Primary outcomes
What the sponsor says the trial is designed to measure.
- Number of Participants With and Without a Successful Correction of Coagulation Factor DeficiencyTime frame: At Day 1 after IP infusion (30 minutes after the end of infusion)
Locations
24 sites in 4 countries. Site status is shown where the registry gives one.
UCLA Health - Ronald Reagan Medical Center
Los Angeles, California · Recruiting
Emory University Hospital
Atlanta, Georgia · Not yet recruiting
University of Chicago Medicine
Chicago, Illinois · Recruiting
University of Kansas Medical Center (KUMC)
Kansas City, Kansas · Not yet recruiting
University of Maryland Medical Center (UMMC)
Baltimore, Maryland · Recruiting
Johns Hopkins Medicine
Baltimore, Maryland · Not yet recruiting
Cooper University Healthcare
Camden, New Jersey · Not yet recruiting
North Shore University Hospital
Manhasset, New York · Not yet recruiting
University of Cincinnati
Cincinnati, Ohio · Recruiting
OUHSC (University of Oklahoma Health Sciences Center)
Oklahoma City, Oklahoma · Recruiting
Oregon Health & Sciences University
Portland, Oregon · Recruiting
Thomas Jefferson University Hospital
Philadelphia, Pennsylvania · Recruiting
Vanderbilt University Medical Center (VUMC)
Nashville, Tennessee · Not yet recruiting
UT Southwestern Medical Center
Dallas, Texas · Recruiting
University of Utah
Salt Lake City, Utah · Not yet recruiting
University of Virginia Health System
Charlottesville, Virginia · Recruiting
Kingston Health Science Center
Kingston, Ontario, Canada · Not yet recruiting
London Health Sciences Center - University Campus
London, Ontario, Canada · Recruiting
University of Toronto - St. Michael's Hospital (SMH) - Keenan Research Centre for Biomedical Science
Toronto, Ontario, Canada · Recruiting
Universite de Montreal-Institut de Cardiologie de Montreal (ICM) Montreal Heart Institute (MHI)
Montreal, Quebec, Canada · Recruiting
Kyushu University Hospital
Fukuoka, Fukuoka, Japan · Recruiting
National Cerebral and Cardiovascular Center
Suita, Osaka, Japan · Recruiting
Sakakibara Heart Institute
Fuchu-shi, Tokyo, Japan · Recruiting
Hospital Civil de Guadalajara
Guadalajara, Jalisco, Mexico · Not yet recruiting
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.